Results 51 to 60 of about 134,028 (256)

Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential

open access: yesAdvanced Healthcare Materials, EarlyView.
Mitochondria‐targeted nanotherapies emerge as a promising strategy for combating aging‐associated neurodegenerative disorders (NDs) by restoring mitochondrial function, reducing oxidative stress, and improving neuronal survival. Recent advances in nanotechnology, therapeutic delivery, and translational research are highlighted, providing insights into ...
Dnyandev G. Gadhave   +8 more
wiley   +1 more source

A new interleukin to treat arthrites: anti-interleukin-6 [PDF]

open access: yesEinstein (São Paulo), 2009
Immunopathological aspects of interleukin-6 are analyzed, as well as the clinical use of tocilizumab, its safety and efficacy. Several studies have demonstrated that the blockade of interleukin-6 may bring a therapeutic benefit to rheumatoid arthritis ...
Morton Aaron Scheinberg
doaj  

Biointegrated Battery‐Based Electroceuticals

open access: yesAdvanced Materials, EarlyView.
Biointegrated batteries go beyond passive power to serve as active therapeutic platforms for delivering programmable electrical cues and bioactive agents. This review examines their mechanisms and applications and provides a framework to guide battery‐based therapeutic design and clinical translation.
Yan Zhou   +6 more
wiley   +1 more source

Original paper Predictors of juvenile idiopathic arthritis course

open access: yesRheumatology, 2015
Introduction : Juvenile idiopathic arthritis (JIA) is a heterogeneous group of inflammatory diseases of joints in children with various and often unfavourable prognosis.
Jaryna J. Bojko   +2 more
doaj   +1 more source

Extrusion Bioprinting for Wound Healing: Innovations in Functionalized Bioinks and Bioprinting Technology

open access: yesAdvanced Materials Technologies, EarlyView.
Extrusion‐based bioprinting (EBB) has emerged as a versatile biofabrication platform capable of precisely depositing bioinks composed of biomaterials, cells, and bioactive agents to generate patient‐specific, biomimetic skin constructs. This paper presents a state‐of‐the‐art and forward‐looking overview of EBB for wound healing, encompassing printing ...
Hien‐Phuong Le   +4 more
wiley   +1 more source

Immunological recovery in patients with pulmonary tuberculosis after intensive phase treatment

open access: yesJournal of International Medical Research, 2018
Objectives This study aimed to examine the change and significance of immune parameters in patients with sputum smear-positive pulmonary tuberculosis (TB) after 2 months of intensive phase anti-TB treatment.
Xuejiao Luo   +4 more
doaj   +1 more source

ST2: Current status

open access: yesIndian Heart Journal, 2018
Cardiovascular diseases are leading cause of mortality and morbidity, and are responsible for 1 out of every 6 deaths in the United States.1 Cardiac remodeling is an important determinant of long term outcomes and occurrence of heart failure (HF).
Aditi Dattagupta, Sathyamurthy Immaneni
doaj   +1 more source

A 3D Human Bone and Bone Marrow‐on‐a‐Chip Model for In Vitro Bone Remodeling and Immune Cell Maintenance

open access: yesAdvanced Science, EarlyView.
This study presents a human Bone (and Bone Marrow)‐on‐a‐Chip model based on native human bone scaffolds and autologous cells. Dynamic perfusion and sequential cell seeding replicate the physiological bone remodeling process in vitro, enabling the long‐term culture of functional, mature bone marrow immune subpopulations.
Nina Stelzer   +17 more
wiley   +1 more source

Serum levels of interleukin-6 are not dependent on the kidney function

open access: yesMediators of Inflammation, 1992
Interleukin-6, also named B-cell stimulatory factor, is a glycoprotein with a molecular weight of 26 kDa. Increased serum levels of interleukin-6 (IL-6) are found in several disease conditions.
L. Nässberger
doaj   +1 more source

Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy

open access: yesArchives of Medical Science, 2016
Introduction: Increased expression of interleukin-6 (IL-6) has been described in left ventricular dysfunction in the course of chronic heart failure.
Katarzyna Ptaszynska-Kopczynska   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy